Narayana Hrudayalaya Ltd
Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
- Market Cap ₹ 37,392 Cr.
- Current Price ₹ 1,830
- High / Low ₹ 2,372 / 1,171
- Stock P/E 47.3
- Book Value ₹ 177
- Dividend Yield 0.25 %
- ROCE 20.6 %
- ROE 24.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 43.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Cons
- Stock is trading at 10.3 times its book value
- The company has delivered a poor sales growth of 11.9% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,095 | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 5,018 | 5,483 | 5,717 | |
989 | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,845 | 4,207 | 4,407 | |
Operating Profit | 106 | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,173 | 1,276 | 1,310 |
OPM % | 10% | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 23% | 23% | 23% |
39 | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 70 | 84 | 85 | |
Interest | 31 | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 146 | 158 |
Depreciation | 57 | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 242 | 278 | 302 |
Profit before tax | 57 | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 889 | 936 | 936 |
Tax % | 38% | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | |
29 | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 786 | |
EPS in Rs | 974.49 | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 38.43 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 12% |
3 Years: | 14% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | 48% |
5 Years: | 44% |
3 Years: | 32% |
TTM: | -2% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 43% |
3 Years: | 42% |
1 Year: | 50% |
Return on Equity | |
---|---|
10 Years: | 19% |
5 Years: | 25% |
3 Years: | 29% |
Last Year: | 24% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Reserves | 580 | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 |
333 | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | |
242 | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,210 | |
Total Liabilities | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,265 |
738 | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,282 | |
CWIP | 20 | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 70 |
Investments | 51 | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 |
346 | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,829 | |
Total Assets | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,265 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
110 | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 | |
-168 | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 | |
57 | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 488 | 544 | |
Net Cash Flow | -1 | -6 | 42 | 28 | -22 | 89 | 7 | -2 | 59 | -4 | 97 | 205 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 45 | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 |
Inventory Days | 64 | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 42 | 35 |
Days Payable | 198 | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 205 | 185 |
Cash Conversion Cycle | -90 | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -132 | -112 |
Working Capital Days | 2 | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | 47 |
ROCE % | 8% | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 27% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
10h - Newspaper publication of the un-audited (Standalone and consolidated) financial results for the quarter ended June 30 2025
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1d - Revised Investors presentation for the quarter ended June 30, 2025
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Newspaper publication relating to 25th Annual General Meeting to be held via VC/OAVM
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1 Aug - Q1 FY26 revenue ₹15,073 Mn (+15.4% YoY), EBITDA ₹3,607 Mn, PAT ₹1,961 Mn; operational highlights and call invite.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
1 Aug - Investors presentation for the quarter ended June 30 2025
Annual reports
Concalls
-
Aug 2025TranscriptNotesPPT
-
Aug 2025TranscriptNotesPPT
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptNotesPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016TranscriptNotesPPT
Hospital Portfolio[1][2]
- India: 19 owned/operated hospitals, 2 heart centers, 18 clinics, and dialysis centers.
- Cayman Islands: 1 hospital.
** - Total:** 40 healthcare facilities with 5,789 operational beds (including Cayman).